Takeda Pharmaceutical is a biopharmaceutical company. It develops and markets pharmaceutical products in gastroenterology, rare diseases including rare metabolic, rare hematology and heredity angioedema, oncology, neuroscience, as well as plasma-derived therapies and vaccines. Takeda's key products in its key business areas include the following 14 global brands: ENTYVIO, GATTEX/REVESTIVE, ALOFISEL, NATPARA, ADYNOVATE/ADYNOVI, TAKHZYRO, ELAPRASE, VPRIV, GAMMAGARD LIQUID/KIOVIG, HYQVIA, CUVITRU, ALBUMIN/FLEXBUMIN, NINLARO, and ALUNBRIG.
Gross profit (H1, 2021)
Gross profit margin (H1, 2021), %
Net income (H1, 2021)
EBIT (H1, 2021)
Market capitalization (21-Jul-2021)
Closing stock price (21-Jul-2021)
|JPY||Q1, 2019||Q2, 2019||Q3, 2019||Q1, 2020||Q2, 2020||Q3, 2020||Q1, 2021||Q2, 2021|
Depreciation and Amortization
|Company Name||Date||Deal Size|
|PvP Biologics||February 26, 2020||$330 m|
|Shire||April 25, 2018||$62 b|
|TiGenix||January 05, 2018||€520 m|
|ARIAD Pharmaceuticals||January 09, 2017||$5.2 b|
|Inviragen||May 07, 2013|
|LigoCyte Pharmaceuticals||October 05, 2012||$60 m|
|Intellikine||December 21, 2011||$310 m|
|Nycomed Pharma||May 19, 2011||€9.6 b|
|IDM Pharma , Inc.||June 24, 2009|
|Millennium Pharmaceuticals||February 01, 2008||$8.69 b|
Takeda Pharmaceutical revenue breakdown by business segment: 21.2% from Gastroenterology, 5.2% from Rare Metabolic, 10.2% from Rare Hematology, 12.0% from PDT Immunology, 12.8% from Oncology, 13.3% from Neuroscience and 25.4% from Other
Takeda Pharmaceutical revenue breakdown by geographic segment: 18.0% from Japan, 48.5% from United States, 19.6% from Europe and Canada, 5.0% from Asia (excluding Japan) and 8.9% from Other
When was Takeda Pharmaceutical founded?
Takeda Pharmaceutical was founded in 1781.
Who are Takeda Pharmaceutical key executives?
Takeda Pharmaceutical's key executives are Andrew S. Plump, Masato Iwasaki and Christophe Weber.
How many employees does Takeda Pharmaceutical have?
Takeda Pharmaceutical has 47,495 employees.
What is Takeda Pharmaceutical revenue?
Latest Takeda Pharmaceutical annual revenue is ¥3.3 t.
What is Takeda Pharmaceutical revenue per employee?
Latest Takeda Pharmaceutical revenue per employee is ¥69.3 m.
Who are Takeda Pharmaceutical competitors?
Competitors of Takeda Pharmaceutical include Nipro Corporation, Grifols and Codiak Biosciences.
Where is Takeda Pharmaceutical headquarters?
Takeda Pharmaceutical headquarters is located at 1-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo.
Where are Takeda Pharmaceutical offices?
Takeda Pharmaceutical has offices in Tokyo, Fujisawa, Fukuchiyama, Hikari and in 47 other locations.
How many offices does Takeda Pharmaceutical have?
Takeda Pharmaceutical has 52 offices.
Receive alerts for 300+ data fields across thousands of companies